Gram-positive superinfections: A consequence of modern β-lactam chemotheraphy
- 31 March 1985
- journal article
- Published by Elsevier in Antimicrobic Newsletter
- Vol. 2 (3) , 17-23
- https://doi.org/10.1016/0738-1751(85)90005-x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopeniaAntimicrobial Agents and Chemotherapy, 1984
- Multicenter Clinical Trial of Cefoperazone Sodium in the United StatesThe American Journal of Medicine, 1984
- Multicentered Study of Cefoperazone for Treatment of Intraabdominal Infections and Comparison of Cefoperazone with Cefamandole and Clindamycin Plus Gentamicin for Treatment of Appendicitis and PeritonitisClinical Infectious Diseases, 1983
- Cefoperazone Therapy for Obstetric and Gynecologic InfectionsClinical Infectious Diseases, 1983
- Cefoperazone for the Treatment of Acute Urinary Tract Infection: Multicentered Comparative and Noncomparative StudiesClinical Infectious Diseases, 1983
- Cefoperazone: A Review of Its Antimicrobial Spectrum, β-Lactamase Stability, Enzyme Inhibition, and Other in Vitro CharacteristicsClinical Infectious Diseases, 1983
- Azlocillin, Mezlocillin, and Piperacillin: New Broad-Spectrum PenicillinsAnnals of Internal Medicine, 1982
- Cefotaxime and Cephalosporins: Adverse Reactions in PerspectiveClinical Infectious Diseases, 1982
- Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility testsJournal of Antimicrobial Chemotherapy, 1981
- In vitro evaluation of LY127935 (6059S) compared with cefotaxime, eight other β-lactams and two aminoglycosidesJournal of Antimicrobial Chemotherapy, 1980